<p>BALB/c mice (n = 6) were immunized on day 0 and 21 with rNP (10 µg/dose) alone or co-administered with c-di-AMP (10 µg/dose) by intranasal route, whereas control animals received PBS. All groups were challenged on day 60 with a non-lethal dose of the influenza strain A/Puerto Rico/8/34 (H1N1). Animal body weight was then monitored for 14 days. Results are expressed as average percentage of weight loss.</p
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Balb/c mice (n = 5–10/group//experiment) were immunized three times with 3 weeks interval with ei...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>BALB/c mice (n = 5/group) were immunized twice on day 0 and 16 with 3×10<sup>6</sup> PFU or 3×10<...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Balb/c mice (n = 5–10/group//experiment) were immunized three times with 3 weeks interval with ei...
<p>A–B: Protection against A/California/04/2009 virus challenge. Mice intramuscularly immunized with...
<p>At week 30 post immunization, H5N1 VLP immunized and control (PBS or 5 µg inactivated PR/8/34 H1N...
<p>At week 5, mock vaccinated mice or mice vaccinated with vaccines (3 µg) were challenged intranasa...
<p>Survival rates (A, C) and average body weight loss (B, D) of BALB/c (A, B) or C57BL/6 (C, D) mice...
<p>At week 5, mice vaccinated with clade 2-dervied vaccines were challenged intranasally with a leth...
<p>The immunized mice were intranasally challenged with the reassortant RG2 (clade 2.1) or NIBRG23 (...
<p>At 18 days following the last immunization, all mice in study group B were intranasally challenge...
<p>Mice (n = 6/groups) were immunized subcutaneously on day 0 and 28. All groups were challenged int...
<p>A. Body weight loss in vaccinated/challenged C57/B6 mice. Mice were vaccinated with Pol1, Pol2, A...
<p>BALB/c mice were immunized intranasally or sublingually with 1×10<sup>7</sup> PFU or 1×10<sup>8</...
<p>(A–B) Groups of vaccinated mice and a mock control were intranasally challenged with a lethal dos...
<p>BALB/c mice (n = 5/group) were immunized twice on day 0 and 16 with 3×10<sup>6</sup> PFU or 3×10<...
<p>Groups of mice (n = 4) were immunized 1 or 2 times, 4 weeks apart, with IDLV-NP via either the i....
<p>Groups of mice (n = 5) were intragastrically immunized three times at day 0, 14, and 28 with PBS ...
<p>Balb/c mice (n = 5–10/group//experiment) were immunized three times with 3 weeks interval with ei...